ZA972971B - Method for gene transfer to the central nervous system. - Google Patents
Method for gene transfer to the central nervous system.Info
- Publication number
- ZA972971B ZA972971B ZA9702971A ZA972971A ZA972971B ZA 972971 B ZA972971 B ZA 972971B ZA 9702971 A ZA9702971 A ZA 9702971A ZA 972971 A ZA972971 A ZA 972971A ZA 972971 B ZA972971 B ZA 972971B
- Authority
- ZA
- South Africa
- Prior art keywords
- cells
- nervous system
- central nervous
- gene transfer
- producer cells
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 2
- 210000003169 central nervous system Anatomy 0.000 title 1
- 108090000623 proteins and genes Proteins 0.000 title 1
- 210000004027 cell Anatomy 0.000 abstract 4
- 230000007774 longterm Effects 0.000 abstract 2
- 210000005171 mammalian brain Anatomy 0.000 abstract 2
- 230000000973 chemotherapeutic effect Effects 0.000 abstract 1
- 238000000338 in vitro Methods 0.000 abstract 1
- 239000011159 matrix material Substances 0.000 abstract 1
- 230000003439 radiotherapeutic effect Effects 0.000 abstract 1
- 230000001177 retroviral effect Effects 0.000 abstract 1
- 230000035945 sensitivity Effects 0.000 abstract 1
- 238000002054 transplantation Methods 0.000 abstract 1
- 210000004881 tumor cell Anatomy 0.000 abstract 1
- 230000002476 tumorcidal effect Effects 0.000 abstract 1
- 230000035899 viability Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
- A61K48/0075—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the delivery route, e.g. oral, subcutaneous
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2121/00—Preparations for use in therapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2510/00—Genetically modified cells
- C12N2510/02—Cells for production
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Epidemiology (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US08/629,308 US6210664B1 (en) | 1996-04-08 | 1996-04-08 | Method for gene transfer to the central nervous system |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA972971B true ZA972971B (en) | 1997-11-03 |
Family
ID=24522456
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA9702971A ZA972971B (en) | 1996-04-08 | 1997-04-08 | Method for gene transfer to the central nervous system. |
Country Status (13)
| Country | Link |
|---|---|
| US (2) | US6210664B1 (fr) |
| EP (1) | EP0927043B8 (fr) |
| JP (2) | JP2000508641A (fr) |
| AT (1) | ATE347903T1 (fr) |
| AU (1) | AU724537C (fr) |
| CA (1) | CA2251232C (fr) |
| DE (1) | DE69737101T2 (fr) |
| DK (1) | DK0927043T3 (fr) |
| ES (1) | ES2277356T3 (fr) |
| PT (1) | PT927043E (fr) |
| TW (1) | TWI222870B (fr) |
| WO (1) | WO1997037684A1 (fr) |
| ZA (1) | ZA972971B (fr) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6210664B1 (en) * | 1996-04-08 | 2001-04-03 | New York University Medical Center | Method for gene transfer to the central nervous system |
| CA2647246C (fr) * | 2006-03-30 | 2015-06-23 | Research Foundation Of City University Of New York | Procedes de stimulation de regeneration neuronale faisant intervenir l'inhibiteur secretoire de la protease du leucocyte (slpi) |
| KR20260007295A (ko) | 2018-05-24 | 2026-01-13 | 셀라니즈 이브이에이 퍼포먼스 폴리머스 엘엘씨 | 거대 분자 약물 화합물의 지속적인 방출을 위한 이식가능 장치 |
| MX2020012459A (es) | 2018-05-24 | 2021-04-28 | Celanese Eva Performance Polymers Llc | Dispositivo implantable para liberacion sostenida de un compuesto de farmaco macromolecular. |
| EP3803866A4 (fr) | 2018-05-24 | 2022-03-16 | Nureva Inc. | Procédé, appareil et supports lisibles par ordinateur pour gérer des sources sonores semi-constantes (persistantes) dans des zones de capture/foyer de microphones |
| BR112023022439A2 (pt) | 2021-04-26 | 2023-12-26 | Celanese Eva Performance Polymers Llc | Dispositivo implantável para liberação sustentada de um composto de fármaco macromolecular |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE117375T1 (de) * | 1987-09-11 | 1995-02-15 | Whitehead Biomedical Inst | Transduktionsveränderte fibroblasten und ihre anwendung. |
| US5650148A (en) * | 1988-12-15 | 1997-07-22 | The Regents Of The University Of California | Method of grafting genetically modified cells to treat defects, disease or damage of the central nervous system |
| DE69133205T2 (de) * | 1990-10-19 | 2003-12-11 | New York University, New York | Eine methode zur transplantation von zellen in das gehirn und ihre therapeutische verwendung |
| US5618531A (en) * | 1990-10-19 | 1997-04-08 | New York University | Method for increasing the viability of cells which are administered to the brain or spinal cord |
| US5529774A (en) * | 1991-08-13 | 1996-06-25 | The Regents Of The University Of California | In vivo transfer of the HSV-TK gene implanted retroviral producer cells |
| AU3586993A (en) * | 1992-01-23 | 1993-09-01 | New York University | A method for transplanting cells into the brain and therapeutic uses therefor |
| AU688321B2 (en) * | 1993-04-21 | 1998-03-12 | Institut Pasteur | Biocompatible implant for the expression and secretion in vivo of a therapeutic compound |
| SG48813A1 (en) * | 1993-08-12 | 1998-05-18 | Cytotherapeutics Inc | Improved composition and methods for the delivery of biologically active molecules using genetically altered cells contained in biocompatible immunoisolatory capsules |
| US5688773A (en) * | 1994-08-17 | 1997-11-18 | The General Hospital Corporation | Method of selectively destroying neoplastic cells |
| US6210664B1 (en) * | 1996-04-08 | 2001-04-03 | New York University Medical Center | Method for gene transfer to the central nervous system |
-
1996
- 1996-04-08 US US08/629,308 patent/US6210664B1/en not_active Expired - Fee Related
-
1997
- 1997-04-07 PT PT97920192T patent/PT927043E/pt unknown
- 1997-04-07 AU AU24449/97A patent/AU724537C/en not_active Ceased
- 1997-04-07 CA CA002251232A patent/CA2251232C/fr not_active Expired - Fee Related
- 1997-04-07 JP JP9536418A patent/JP2000508641A/ja not_active Withdrawn
- 1997-04-07 ES ES97920192T patent/ES2277356T3/es not_active Expired - Lifetime
- 1997-04-07 DK DK97920192T patent/DK0927043T3/da active
- 1997-04-07 EP EP97920192A patent/EP0927043B8/fr not_active Expired - Lifetime
- 1997-04-07 WO PCT/US1997/005746 patent/WO1997037684A1/fr not_active Ceased
- 1997-04-07 AT AT97920192T patent/ATE347903T1/de not_active IP Right Cessation
- 1997-04-07 DE DE69737101T patent/DE69737101T2/de not_active Expired - Fee Related
- 1997-04-08 ZA ZA9702971A patent/ZA972971B/xx unknown
- 1997-04-09 TW TW086104516A patent/TWI222870B/zh not_active IP Right Cessation
-
2000
- 2000-12-04 US US09/730,328 patent/US6565845B2/en not_active Expired - Fee Related
-
2004
- 2004-08-11 JP JP2004234879A patent/JP2004337176A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| DK0927043T3 (da) | 2007-04-10 |
| CA2251232A1 (fr) | 1997-10-16 |
| EP0927043A4 (fr) | 2004-09-01 |
| WO1997037684A1 (fr) | 1997-10-16 |
| ATE347903T1 (de) | 2007-01-15 |
| JP2000508641A (ja) | 2000-07-11 |
| US20010003585A1 (en) | 2001-06-14 |
| JP2004337176A (ja) | 2004-12-02 |
| AU724537B2 (en) | 2000-09-21 |
| AU724537C (en) | 2001-07-19 |
| AU2444997A (en) | 1997-10-29 |
| CA2251232C (fr) | 2005-10-25 |
| EP0927043B8 (fr) | 2007-04-18 |
| PT927043E (pt) | 2007-03-30 |
| TWI222870B (en) | 2004-11-01 |
| EP0927043A1 (fr) | 1999-07-07 |
| DE69737101D1 (de) | 2007-01-25 |
| HK1021801A1 (en) | 2000-07-07 |
| US6210664B1 (en) | 2001-04-03 |
| US6565845B2 (en) | 2003-05-20 |
| DE69737101T2 (de) | 2007-05-31 |
| EP0927043B1 (fr) | 2006-12-13 |
| ES2277356T3 (es) | 2007-07-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Devine | Mesenchymal stem cells: will they have a role in the clinic? | |
| Kim et al. | Brain transplantation of human neural stem cells transduced with tyrosine hydroxylase and GTP cyclohydrolase 1 provides functional improvement in animal models of Parkinson disease | |
| Heath | Cells for tissue engineering | |
| EP1007630A4 (fr) | Lignees de cellules tueuses naturelles et procedes d'utilisation | |
| GR3036216T3 (en) | Liver reserve cells. | |
| ATE368103T1 (de) | Isolierung, vermehrung und gezielte differenzierung von zäugetierstammzellen des zentralnervensystems | |
| CA2407505A1 (fr) | Cellules hepatocytes de lignee derivees de cellules souches pluripotentielles | |
| SE0201328D0 (sv) | Hematopoietic differentiation of human embryonic stem cells | |
| CA2402299A1 (fr) | Culture de cellules souches embryonnaires de primates exempte de serum | |
| IL87196A (en) | Serum free medium for the growthof insect cells and expressionof products thereby | |
| WO1997012960A3 (fr) | Support solide de culture de cellules et en particulier de cellules hepatiques, reacteur biologique utilisant ledit support et leur emploi dans un systeme de foie bio-artificiel | |
| ATE297987T1 (de) | Bedingte immortalisierung von zellen | |
| Kasai et al. | Cancer stem cells converted from pluripotent stem cells and the cancerous niche | |
| Yoshida et al. | Morphology and increased growth rate of atherosclerotic intimal smooth-muscle cells | |
| ZA972971B (en) | Method for gene transfer to the central nervous system. | |
| EP1666589A1 (fr) | Procede de production de lymphocytes cytotoxiques | |
| IL137304A (en) | Expanded and genetically modified populations of human hematopoietic stem cells | |
| Dartsch et al. | Human vascular smooth muscle cells in culture: growth characteristics and protein pattern by use of serum-free media supplements. | |
| Glick et al. | DNA-induced pigment production in a hamster cell line | |
| DE69635513D1 (de) | Menschliche pancreas zellinien: entwicklungen und anwendungen | |
| Merrill | Clonal derivation of a rat muscle cell strain that forms contraction-competent myotubes | |
| Cossu et al. | Similar glycopeptides in normal chondroblasts and in Rous sarcoma virus-transformed fibroblasts. | |
| Karikusa et al. | The restoration of the functions of serially passaged calf hepatocytes by spheroid formation | |
| DE69737597D1 (de) | Vektoren zur inhibierung von viralem und tumorwachstum | |
| IL69928A (en) | Hydrogen uptake gene cosmids,process of constructing same and use thereof |